课题基金 / 基金详情

Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies

Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies
用于有效分离广泛中和抗体的新型 HIV-1 Env 三聚体探针
批准号:
10080301
负责人:
Xueling Wu
金额:
$49.72万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-19 至 2021-01-31

项目摘要

项目成果

Xueling Wu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY HIV-1 envelope (Env) probes are key to the isolation of broadly neutralizing antibodies (bnAbs) and the HIV-1 bnAbs are particularly useful to inform and guide Env immunogen design. As current probes and methods have limitations that hinder efficient bnAb isolation from large numbers of individuals, we propose to develop novel VSV-based probes to display dense HIV-1 Env trimers on the surface to isolate bnAbs. We hypothesize that properly constructed gp140.VSV probes provide a powerful tool for bnAb isolation and allow efficient identification of bnAbs from a large number (n>50) of clade-B and non-B clade infected individuals, some with undefined novel epitopes. To test this hypothesis, we collaborate with Dr. Andres Finzi to study samples from a clade-B infected cohort based in Montreal, Canada, and with Dr. Phillipe Nyambi to study samples from a multi-clade infected cohort based in Yaounde, Cameroon. We have screened 111 Montreal and 260 Cameroon plasmas and identified 32 and 13 donors with bnAb activity, respectively. We propose to 1) construct, characterize, and optimize gp140.VSV probes for various clade-B and non-B Envs, 2) apply gp140.VSV probes to isolate bnAbs from >50 clade-B and non-B clade infected broad neutralizers, and 3) determine the epitopes of newly isolated bnAbs and define new bnAb genetic compositions. In pilot experiments, we generated a gp140.VSV probe displaying the HIV-1 AD17 Env trimer on the surface; using this probe, we recovered two distinct and novel bnAbs from a clade-B infected Montreal donor. This preliminary result supports our hypothesis and provides a proof-of-concept that the gp140.VSV probe can lead to the isolation of novel bnAbs. We anticipate that >50 new bnAbs will be identified by this probing method and some of them will define new Env targets and bnAb genetic compositions. The addition of these bnAbs will complement others to expand the bnAb repertoire and advance our understanding of the bnAb epitopes and genetic compositions, thus facilitating Env immunogen design and post-immunization analysis.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.chom.2021.06.001
发表时间: 2021-07-14
期刊: Cell host & microbe
影响因子: 30.3
作者: [Tauzin A, Nayrac M, Benlarbi M, Gong SY, Gasser R, Beaudoin-Bussières G, Brassard N, Laumaea A, Vézina D, Prévost J, Anand SP, Bourassa C, Gendron-Lepage G, Medjahed H, Goyette G, Niessl J, Tastet O, Gokool L, Morrisseau C, Arlotto P, Stamatatos L, McGuire AT, Larochelle C, Uchil P, Lu M, Mothes W, De Serres G, Moreira S, Roger M, Richard J, Martel-Laferrière V, Duerr R, Tremblay C, Kaufmann DE, Finzi A]
通讯作者: Finzi A
DOI: 10.3390/microorganisms9071389
发表时间: 2021-06-27
期刊: Microorganisms
影响因子: 4.5
作者: [Duerr R, Crosse KM, Valero-Jimenez AM, Dittmann M]
通讯作者: Dittmann M
DOI: 10.1016/j.xcrm.2021.100290
发表时间: 2021-06-15
期刊: Cell reports. Medicine
影响因子: --
作者: [Anand SP, Prévost J, Nayrac M, Beaudoin-Bussières G, Benlarbi M, Gasser R, Brassard N, Laumaea A, Gong SY, Bourassa C, Brunet-Ratnasingham E, Medjahed H, Gendron-Lepage G, Goyette G, Gokool L, Morrisseau C, Bégin P, Martel-Laferrière V, Tremblay C, Richard J, Bazin R, Duerr R, Kaufmann DE, Finzi A]
通讯作者: Finzi A
DOI: 10.1038/s41467-021-26846-z
发表时间: 2021-11-09
期刊: Nature communications
影响因子: 16.6
作者: [Chan KW, Luo CC, Lu H, Wu X, Kong XP]
通讯作者: Kong XP
6
    Characterization of HIV-1 IgA bNAbs and ADCP function
    Characterization of HIV-1 IgA bNAbs and ADCP function
    Characterization of HIV-1 IgA bNAbs and ADCP function
    Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies
    国内基金
    海外基金
    人类免疫缺陷病毒(HIV)总核酸检测试剂盒
    HIV相关肺癌免疫微环境中关键免疫细胞亚群的功能特征与调控机制研究
    基于深度测序与SNV 芯片的HIV重复感染与毒株重组机制研究
    • 批准号:
      2026JJ81281
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      徐艳
    • 依托单位:
    PGT123中和抗体修饰的工程化载肽囊泡疫苗通过诱导CD4+ T细胞极化在抗HIV感染中的应用和机制研究